Calcium Silicate
PreclinicalSmall molecule
Calcium Silicate is one of 41 small molecule programs targeting Treatment. It is currently in Preclinical.
3
Indications
10
Total Trials
4
Active Trials
40
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
332 competitors in Treatment
#DrugCompanyPhaseTrials
1Biltricide
BayerPreclinical
Dexilant
TakedaPreclinical
Niclocide
BayerPreclinical
Minipress
PfizerPreclinical
Theo-Dur
PfizerPreclinical
Levulan
Sun Pharmaceutical Industries, Inc.Preclinical
Hivid
CConrado Roberto Hoffmann Filho
Preclinical
Foscavir
CClinigen, Inc.
Preclinical
Valium
Akero TherapeuticsPreclinical
Clomid
FerringPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Intracanal Medicament2 trials
Antibacterial Effect of Two Different Intracanal Medicaments and Their Effect on Post-operative Pain
Not yet recruiting·—·Phase 4·NCT07388888·52 enrolled
Treatment2 trials
Effect of Calcium Silicate-Based Root Canal Medicament After Retreatment
Completed·—·N/A·NCT06779370·60 enrolled
Calcium Hydroxide1 trial
Comparison of the Effects of N-acetylcysteine, Calcium Hydroxide, and Double Antibiotic Paste
Completed·—·N/A·NCT07340944·45 enrolled
Indirect Pulp Cap1 trial
Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth
Recruiting·—·Phase 4·NCT06683833·35 enrolled
3 more indications
Bone Infection1 trial
Inflammatory Mediators1 trial
Effect of Calcium Silicate Based Root Canal Medicament on Inflammatory Mediators
Completed·—·N/A·NCT06307678·60 enrolled
Unspecified1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Calcium Silicate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMansoura University